메뉴 건너뛰기




Volumn 26, Issue 11, 2013, Pages 1525-1535

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer

Author keywords

ARID1A; endometrial cancer; Lynch syndrome; microsatellite instability

Indexed keywords

AT RICH INTERACTIVE DOMAIN 1A PROTEIN; K RAS PROTEIN; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG;

EID: 84887035038     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.96     Document Type: Article
Times cited : (168)

References (40)
  • 1
    • 84868320535 scopus 로고    scopus 로고
    • Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
    • Liang H, Cheung LW, Li J, et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res 2012;22:2120-2129.
    • (2012) Genome Res , vol.22 , pp. 2120-2129
    • Liang, H.1    Cheung, L.W.2    Li, J.3
  • 2
    • 80155131218 scopus 로고    scopus 로고
    • ARIDIA, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers
    • Guan B, Wang TL, I Shih. ARIDIA, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 2011;71:6718-6727.
    • (2011) Cancer Res , vol.71 , pp. 6718-6727
    • Guan, B.1    Wang, T.L.2    Shih, I.3
  • 3
    • 84866024623 scopus 로고    scopus 로고
    • Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    • Xiao W, Awadallah A, Xin W. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. Int J Clin Exp Pathol 2012; 5:642-650.
    • (2012) Int J Clin Exp Pathol , vol.5 , pp. 642-650
    • Xiao, W.1    Awadallah, A.2    Xin, W.3
  • 4
    • 78650991499 scopus 로고    scopus 로고
    • Clinicopathological significance of loss of ARID1A Immunoreactivity in ovarian clear cell carcinoma
    • Maeda D, Mao TL, Fukayama M, et al. Clinicopathological significance of loss of ARID1A Immunoreactivity in ovarian clear cell carcinoma. Int J Mol Sci 2010;11:5120-5128.
    • (2010) Int J Mol Sci , vol.11 , pp. 5120-5128
    • Maeda, D.1    Mao, T.L.2    Fukayama, M.3
  • 5
    • 84871821809 scopus 로고    scopus 로고
    • Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms
    • Maeda D, Shih I. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013;20:45-52.
    • (2013) Adv Anat Pathol , vol.20 , pp. 45-52
    • Maeda, D.1    Shih, I.2
  • 6
    • 79953797962 scopus 로고    scopus 로고
    • Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
    • Guan B, Mao TL, Panuganti PK, et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 2011;35:625-632.
    • (2011) Am J Surg Pathol , vol.35 , pp. 625-632
    • Guan, B.1    Mao, T.L.2    Panuganti, P.K.3
  • 7
    • 79958238185 scopus 로고    scopus 로고
    • Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
    • Wiegand KC, Lee AF, Al-Agha OM, et al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 2011;224:328-333.
    • (2011) J Pathol , vol.224 , pp. 328-333
    • Wiegand, K.C.1    Lee, A.F.2    Al-Agha, O.M.3
  • 8
    • 84870674891 scopus 로고    scopus 로고
    • Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
    • Rahman M, Nakayama K, Rahman MT, et al. Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer. Hum Pathol 2012;44:103-109.
    • (2012) Hum Pathol , vol.44 , pp. 103-109
    • Rahman, M.1    Nakayama, K.2    Rahman, M.T.3
  • 10
    • 79959653996 scopus 로고    scopus 로고
    • SWI/SNF nucleosome remodellers and cancer
    • Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011;11:481-492.
    • (2011) Nat Rev Cancer , vol.11 , pp. 481-492
    • Wilson, B.G.1    Roberts, C.W.2
  • 11
    • 84872868948 scopus 로고    scopus 로고
    • ARID1A mutations in cancer: Another epigenetic tumor suppressor?
    • Wu JN, Roberts CW. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 2013;3:35-43.
    • (2013) Cancer Discov , vol.3 , pp. 35-43
    • Wu, J.N.1    Roberts, C.W.2
  • 12
    • 82255183148 scopus 로고    scopus 로고
    • Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
    • Wang K, Kan J, Yuen ST, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 2011;43:1219-1223.
    • (2011) Nat Genet , vol.43 , pp. 1219-1223
    • Wang, K.1    Kan, J.2    Yuen, S.T.3
  • 13
    • 78650878985 scopus 로고    scopus 로고
    • A proposed model for endometrial serous carcinogenesis
    • Zheng W, Xiang L, Fadare O, et al. A proposed model for endometrial serous carcinogenesis. Am J Surg Pathol 2011;35:e1-e14.
    • (2011) Am J Surg Pathol , vol.35
    • Zheng, W.1    Xiang, L.2    Fadare, O.3
  • 14
    • 84867403968 scopus 로고    scopus 로고
    • ARID1A expression loss in gastric cancer: Pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability
    • Abe H, Maeda D, Hino R, et al. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability. Virchows Arch 2012;461:367-377.
    • (2012) Virchows Arch , vol.461 , pp. 367-377
    • Abe, H.1    Maeda, D.2    Hino, R.3
  • 15
    • 84863746056 scopus 로고    scopus 로고
    • Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer
    • Wang DD, Chen YB, Pan K, et al. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. PLoS One 2012;7:e40364.
    • (2012) PLoS One , vol.7
    • Wang, D.D.1    Chen, Y.B.2    Pan, K.3
  • 16
    • 84857467474 scopus 로고    scopus 로고
    • Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
    • Jones S, Li M, Parsons DW, et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat 2012;33:100-103.
    • (2012) Hum Mutat , vol.33 , pp. 100-103
    • Jones, S.1    Li, M.2    Parsons, D.W.3
  • 17
    • 77956356649 scopus 로고    scopus 로고
    • Methylation profiles of endometrioid and serous endometrial cancers
    • Seeber LM, Zweemer RP, Marchionni L, et al. Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 2010;17:663-673.
    • (2010) Endocr Relat Cancer , vol.17 , pp. 663-673
    • Seeber, L.M.1    Zweemer, R.P.2    Marchionni, L.3
  • 18
    • 84864413479 scopus 로고    scopus 로고
    • Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation
    • Nout RA, Bosse T, Creutzberg CL, et al. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. Gynecol Oncol 2012;126:466-473.
    • (2012) Gynecol Oncol , vol.126 , pp. 466-473
    • Nout, R.A.1    Bosse, T.2    Creutzberg, C.L.3
  • 19
    • 0033645557 scopus 로고    scopus 로고
    • Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients
    • de Leeuw WJ, Dierssen J, Vasen HF, et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol 2000;192:328-335.
    • (2000) J Pathol , vol.192 , pp. 328-335
    • De Leeuw, W.J.1    Dierssen, J.2    Vasen, H.F.3
  • 21
    • 84876900933 scopus 로고    scopus 로고
    • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts
    • Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013;0:1-13.
    • (2013) Gut , vol.0 , pp. 1-13
    • Vasen, H.F.1    Blanco, I.2    Aktan-Collan, K.3
  • 22
    • 79952381358 scopus 로고    scopus 로고
    • Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allelespecific qPCR
    • van ER, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allelespecific qPCR. PLoS One 2011;6:e17791.
    • (2011) PLoS One , vol.6
    • Van Er Licht, J.1    Schrumpf, M.2
  • 23
    • 77951844096 scopus 로고    scopus 로고
    • Early onset MSI-H colon cancer with MLH1 promoter methylation is there a genetic predisposition?
    • van Roon EH, van PM, Middeldorp A, et al. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? BMC Cancer 2010;10:180.
    • (2010) BMC Cancer , vol.10 , pp. 180
    • Van Roon, E.H.1    Van Pm Middeldorp, A.2
  • 25
    • 84875218081 scopus 로고    scopus 로고
    • ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
    • Werner HM, Berg A, Wik E, et al. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Mod Pathol 2012;26:428-434.
    • (2012) Mod Pathol , vol.26 , pp. 428-434
    • Werner, H.M.1    Berg, A.2    Wik, E.3
  • 26
    • 77957946398 scopus 로고    scopus 로고
    • ARID1A mutations in endometriosis-associated ovarian carcinomas
    • Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010;363:1532-1543.
    • (2010) N Engl J Med , vol.363 , pp. 1532-1543
    • Wiegand, K.C.1    Shah, S.P.2    Al-Agha, O.M.3
  • 27
    • 77954950405 scopus 로고    scopus 로고
    • Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: A comparative analysis emphasizing the importance of distinguishing between these two groups
    • Bartosch C, Exposito MI, Lopes JM. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups. Int J Surg Pathol 2010;18:286-291.
    • (2010) Int J Surg Pathol , vol.18 , pp. 286-291
    • Bartosch, C.1    Exposito, M.I.2    Lopes, J.M.3
  • 28
    • 77951664346 scopus 로고    scopus 로고
    • Endometrial carcinoma: Controversies in histopathological assessment of grade and tumour cell type
    • Clarke BA, Gilks CB. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol 2010;63:410-415.
    • (2010) J Clin Pathol , vol.63 , pp. 410-415
    • Clarke, B.A.1    Gilks, C.B.2
  • 29
    • 47149101636 scopus 로고    scopus 로고
    • Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer
    • Medina PP, Sanchez-Cespedes M. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer. Epigenetics 2008;3:64-68.
    • (2008) Epigenetics , vol.3 , pp. 64-68
    • Medina, P.P.1    Sanchez-Cespedes, M.2
  • 30
    • 0037308717 scopus 로고    scopus 로고
    • Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: Correlation with poor prognosis
    • Reisman DN, Sciarrotta J, Wang W, et al. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 2003;63:560-566. (Pubitemid 36158131)
    • (2003) Cancer Research , vol.63 , Issue.3 , pp. 560-566
    • Reisman, D.N.1    Sciarrotta, J.2    Wang, W.3    Funkhouser, W.K.4    Weissman, B.E.5
  • 31
    • 0034326257 scopus 로고    scopus 로고
    • BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines
    • Wong AK, Shanahan F, Chen Y, et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000;60:6171-6177.
    • (2000) Cancer Res , vol.60 , pp. 6171-6177
    • Wong, A.K.1    Shanahan, F.2    Chen, Y.3
  • 32
    • 84858155638 scopus 로고    scopus 로고
    • Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas
    • Dal MM, Hong SM, Hebbar S, et al. Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol 2012;43:585-591.
    • (2012) Hum Pathol , vol.43 , pp. 585-591
    • Dal, M.M.1    Hong, S.M.2    Hebbar, S.3
  • 33
    • 80053358456 scopus 로고    scopus 로고
    • INI1-deficient tumors: Diagnostic features and molecular genetics
    • Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011;35:e47-e63.
    • (2011) Am J Surg Pathol , vol.35
    • Hollmann, T.J.1    Hornick, J.L.2
  • 35
    • 84859427109 scopus 로고    scopus 로고
    • Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
    • Yamamoto S, Tsuda H, Takano M, et al. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod Pathol 2011;25:615-624.
    • (2011) Mod Pathol , vol.25 , pp. 615-624
    • Yamamoto, S.1    Tsuda, H.2    Takano, M.3
  • 36
    • 84860688574 scopus 로고    scopus 로고
    • Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance
    • Zhang X, Zhang Y, Yang Y, et al. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance. Cancer Epidemiol 2012;36:288-293.
    • (2012) Cancer Epidemiol , vol.36 , pp. 288-293
    • Zhang, X.1    Zhang, Y.2    Yang, Y.3
  • 37
    • 84055176558 scopus 로고    scopus 로고
    • Targeting the mTOR/4E-BP pathway in endometrial cancer
    • Korets SB, Czok S, Blank SV, et al. Targeting the mTOR/4E-BP pathway in endometrial cancer. Clin Cancer Res 2011;17:7518-7528.
    • (2011) Clin Cancer Res , vol.17 , pp. 7518-7528
    • Korets, S.B.1    Czok, S.2    Blank, S.V.3
  • 38
    • 84872653446 scopus 로고    scopus 로고
    • Promoter hypermethylation of ARID1A gene is responsible for its low mRNA rxpression in many invasive breast cancers
    • Zhang X, Sun Q, Shan M, et al. Promoter hypermethylation of ARID1A gene is responsible for its low mRNA rxpression in many invasive breast cancers. PLoS One 2013;8:e53931.
    • (2013) PLoS One , vol.8
    • Zhang, X.1    Sun, Q.2    Shan, M.3
  • 39
    • 77957365492 scopus 로고    scopus 로고
    • DNA methylation in endometrial cancer
    • Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics 2010;5:491-498.
    • (2010) Epigenetics , vol.5 , pp. 491-498
    • Tao, M.H.1    Freudenheim, J.L.2
  • 40
    • 84861357097 scopus 로고    scopus 로고
    • Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors
    • McKenna ES, Tamayo P, Cho YJ, et al. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors. Cell Cycle 2012;11:1956-1965.
    • (2012) Cell Cycle , vol.11 , pp. 1956-1965
    • McKenna, E.S.1    Tamayo, P.2    Cho, Y.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.